Robert de Luccia
Founder en ACURX PHARMACEUTICALS, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Robert J.
de Luccia founded Dipexium Pharmaceuticals, Inc. in 2010, where he worked as Executive Chairman from 2014 to 2017 and Acurx Pharmaceuticals, Inc. in 2017, where he is working as Executive Chairman from 2017.
Mr. de Luccia also currently works at IBEX Technologies, Inc., as Lead Independent Director from 2012.
Mr. de Luccia also formerly worked at Immunomedics, Inc., as President & Chief Executive Officer from 1998 to 1999, MacroChem Corp., as Chairman, President & Chief Executive Officer from 2004 to 2009, Morris Plains Property LLC, as Chief Executive Officer, Topigen Pharmaceuticals, Inc., as Director, Pfizer Inc., as Vice President-Marketing & Sales Operations, Sanofi Winthrop, as President, Sterling Winthrop, Inc., as President, and Sanofi-Aventis U.S.
LLC, as President.
Mr. de Luccia received his undergraduate degree and Masters Business Admin degree from Iona College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/04/2024 | 964 782 ( 6.67% ) | 2 M $ | 31/03/2024 | |
IBEX TECHNOLOGIES INC.
0.28% | 22/02/2024 | 68 000 ( 0.28% ) | 71 857 $ | 31/03/2024 |
Cargos activos de Robert de Luccia
| Empresas | Cargo | Inicio |
|---|---|---|
| IBEX TECHNOLOGIES | Director/Board Member | 01/01/2000 |
| ACURX PHARMACEUTICALS, INC. | Founder | 01/07/2017 |
Antiguos cargos conocidos de Robert de Luccia.
| Empresas | Cargo | Fin |
|---|---|---|
Dipexium Pharmaceuticals, Inc.
 Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Founder | 01/04/2017 |
MacroChem Corp.
 MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Chief Executive Officer | 01/01/2009 |
| IMMUNOMEDICS, INC. | Chief Executive Officer | 01/01/1999 |
Sanofi Winthrop
 Sanofi Winthrop Pharmaceuticals: OtherHealth Technology Part of Sanofi, Sanofi Winthrop is a French company that specializes in medicinal chemicals and botanical products. The private company is based in Paris, France. | President | - |
Morris Plains Property LLC
 Morris Plains Property LLC Real Estate DevelopmentFinance Morris Plains Property LLC provides real estate services. The private company is based in Morris Plains, NJ. | Chief Executive Officer | - |
Formación de Robert de Luccia.
| Iona College | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACURX PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 9 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Health Technology |
IBEX Technologies, Inc.
 IBEX Technologies, Inc. Medical SpecialtiesHealth Technology IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada. | Health Technology |
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Health Technology |
Sanofi Winthrop
Sanofi Winthrop Pharmaceuticals: OtherHealth Technology Part of Sanofi, Sanofi Winthrop is a French company that specializes in medicinal chemicals and botanical products. The private company is based in Paris, France. | Health Technology |
Sterling Winthrop, Inc.
 Sterling Winthrop, Inc. Electronics/AppliancesConsumer Durables Part of GSK Plc, Sterling Winthrop, Inc. is a private company that specializes in cameras and duplicating machines. The company is based in Rochester, NY. Sterling Winthrop was acquired by GSK Plc from Eastman Kodak Co. on November 03, 1994 for $2,930 million. | Consumer Durables |
Topigen Pharmaceuticals, Inc.
 Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Topigen Pharmaceuticals, Inc. develops drugs for respiratory diseases. The firm focuses on discovery and development of multiple pathway therapies for respiratory diseases with primary emphasis on asthma, chronic obstructive pulmonary disease, and allergic rhinitis. The company was founded by Paolo Renzi in 2000 and is headquartered in Montréal, Canada. | Health Technology |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
Morris Plains Property LLC
Morris Plains Property LLC Real Estate DevelopmentFinance Morris Plains Property LLC provides real estate services. The private company is based in Morris Plains, NJ. | Finance |
- Bolsa de valores
- Insiders
- Robert de Luccia
